Literature DB >> 8854707

Susceptibility to varicella zoster virus infection in health care workers.

J Gallagher1, B Quaid, B Cryan.   

Abstract

Varicella zoster virus (VZV) is an occupational hazard for a percentage of health care staff. Nine hundred and seventy staff members attending the Occupational Health Department at Cork University Hospital took part in the survey. A latex agglutination assay was used to determine the health care workers immune status to VZV. Of the 970 workers tested, 928 (95.7%) were immune to VZV. The sensitivity, specificity and predictive value of an enquiry regarding a history of chicken-pox was determined on a sample of 206 health care workers. The positive predictive value was 95% (119/125) and the negative predictive value was 11% (4/35). The sensitivity of the enquiry was 79% (119/150), the specificity was 40% (4/10), reducing to 61% (119/195) and 36% (4/11) respectively when individuals with uncertain histories were included in the calculations. The advantages and disadvantages of selective staff screening are discussed. In the authors' opinion all health care workers involved in the clinical care of patients should be screened by serology for past VZV infection before taking up duty and those who are susceptible to VZV should be made aware of the risks and health effects associated with VZV if contracted.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8854707     DOI: 10.1093/occmed/46.4.289

Source DB:  PubMed          Journal:  Occup Med (Lond)        ISSN: 0962-7480            Impact factor:   1.611


  10 in total

1.  Occupational risk of infection by varicella zoster virus in Belgian healthcare workers: a seroprevalence study.

Authors:  G Vandersmissen; G Moens; R Vranckx; A de Schryver; P Jacques
Journal:  Occup Environ Med       Date:  2000-09       Impact factor: 4.402

Review 2.  Economic evaluations of varicella vaccination programmes: a review of the literature.

Authors:  Nancy Thiry; Philippe Beutels; Pierre Van Damme; Eddy Van Doorslaer
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

3.  Seroepidemiology of varicella zoster virus in healthcare workers in Babol, Northern Iran.

Authors:  Masomeh Bayani; Mohammad Reza Hasanjani-Roushan; Sepideh Siadati; Mostafa Javanian; Mahmoud Sadeghi-Haddad-Zavareh; Mehran Shokri; Mehdi Mohammadpour; Amin Zarghami; Samaneh Asghari
Journal:  Caspian J Intern Med       Date:  2013

4.  Vaccine-related varicella-zoster rash in a hospitalized immunocompetent patient.

Authors:  Paul Bernstein; Yoko Furuya; Sharon Steinberg; Brian Scully; Philip Larussa; Anne A Gershon
Journal:  Am J Infect Control       Date:  2011-01-26       Impact factor: 2.918

Review 5.  Predictive value of a history of varicella infection.

Authors:  Candice N Holmes
Journal:  Can Fam Physician       Date:  2005-01       Impact factor: 3.275

6.  Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen.

Authors:  A Sauerbrei; P Wutzler
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

7.  Predictive value of a self-reported history of varicella infection in determining immunity in adults.

Authors:  Candice N Holmes; Karl T Iglar; Brenda J McDowell; Richard H Glazier
Journal:  CMAJ       Date:  2004-11-09       Impact factor: 8.262

8.  Effect of varicella-zoster virus (VZV) fluorescent-antibody-to-membrane-antigen (FAMA) testing on sensitivity of determining VZV immunity in healthcare workers and on furlough days.

Authors:  Lori Rolando; William J Schneider; Sharon Steinberg; Sulin Low; Jeffrey Stiles; Luz Gomez; Anne A Gershon; Arthur E Brown
Journal:  Infect Control Hosp Epidemiol       Date:  2010-09       Impact factor: 3.254

9.  Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization.

Authors:  Margarita Riera-Montes; Kaatje Bollaerts; Ulrich Heininger; Niel Hens; Giovanni Gabutti; Angel Gil; Bayad Nozad; Grazina Mirinaviciute; Elmira Flem; Audrey Souverain; Thomas Verstraeten; Susanne Hartwig
Journal:  BMC Infect Dis       Date:  2017-05-18       Impact factor: 3.090

10.  Changing demographics and immunity to vaccine preventable diseases in people with HIV in Ireland.

Authors:  C Kerr; M Kelleher; S Coughlan; B Crowley; E J O'Reilly; C Bergin
Journal:  BMC Infect Dis       Date:  2022-06-29       Impact factor: 3.667

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.